| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-05 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.26 | 6e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.2 | 8e-05 |